According to FutureWise analysis, the Renal stents market is to reach USD 1 billion by 2027 and is projected to expand at a CAGR of around 4.5% from 2025-2033. Market growth is driven by the rising prevalence of chronic kidney disorders, increased demand for minimally invasive urological procedures, and advancements in stent technology. Additionally, the expanding geriatric population and the rise of lifestyle-related diseases are contributing to this demand.
Renal stenting is a procedure to open the renal arteries – the large blood vessels that carry blood to the kidneys – when they have become blocked due to renal stenosis (narrowing of the renal artery). This is most often caused by atherosclerosis or fibrous disease of the arteries. When a renal artery is clogged, blood flow to the kidneys is affected. Stenting opens the blockage and restores normal blood flow. There are different types of stents are there based on indications includes double pigtail, open end and closed end stents.
Renal artery stenosis can lead to hypertension, pulmonary edema, nephropathy, renal failure, and others. Renal artery stenosis has a huge impact on patient health condition and requires immediate medical attention. Renal stents have huge applications in treating renal artery stenosis and led to the robust growth of the market. Further, increasing prevalence of renal artery stenosis in diabetic patient fuelled the growth. Renal artery stenosis has a huge impact on healthcare systems and is associated with other medical complications. Because of this, renal stents has a huge importance in treating stenosis. Along with this, renal artery stenosis is more advantageous over traditional methods of treatment as it is minimal invasive and decreases other medical complications.
Drug-Eluting Stents: Incorporating medication to prevent restenosis enhances long-term effectiveness.
Covered Stents: This product is designed to minimize the risk of perforation and enhance safety during procedures.